ALPHAMED PRESS IMAGE: ISMAIL HADISOEBROTO DILOGO, PROFESSOR OF MEDICINE AT CIPTO MANGUNKUSUMO CENTRAL HOSPITAL-UNIVERSITAS INDONESIA, CORRESPONDING AUTHOR OF THE STUDY. CREDIT: ALPHAMED PRESS Durham, NC – Critically ill COVID-19 patients treated with non-altered stem cells from umbilical cord connective tissue were more than twice as likely to survive as those who did not have the...
